Posted by Michael Wonder on 23 Oct 2023
Zydus receives US FDA approval for Zituvio to treat adult patients with type 2 diabetes mellitus
20 October 2023 - The company received final approval from the US FDA for its new drug application for Zituvio (sitagliptin) tablets, 25 mg, 50 mg, and 100 mg.
Zydus Lifesciences today announced that the US FDA approved its new drug application for Zituvio (sitagliptin) tablets, 25 mg, 50 mg and 100 mg.
